GARDEN GROVE, Calif., July 19, 2011 /PRNewswire/ — HYCOR
Biomedical, Inc., a leading manufacturer and marketer of in vitro
diagnostic products, today announced that Sean-Xavier Neath, M.D.,
Ph.D., has been appointed as Chief Medical Officer (CMO). In this
role, Dr. Neath will support the company as it works to expand its
product lines and provide additional support for customers.
“We are pleased to welcome Dr. Neath to the HYCOR team and are
confident he will have great impact on key areas of our business,”
said Dick Aderman, CEO, HYCOR. “Given his diverse background in the
academic, clinical and business sectors we look forward to learning
from his experience and leveraging his unique perspective during
this important time of growth for the company.”
Dr. Neath brings extensive knowledge and leadership in the
pharmaceutical and diagnostics industries having served in medical
affairs positions for a number of leading companies, including
BRAHMS USA and Biosite. During his time at BRAHMS USA, Dr. Neath
lead new product development strategies, including clinical trial
design and regulatory submission planning. In addition, Dr. Neath
was responsible for medical education, marketing and reimbursement
program development. In his role at Biosite, Dr. Neath provided
strategic counsel to the business development, marketing, sales and
R&D teams and also developed educational curricula for
physician clients.
“I’m pleased to join the HYCOR team to identify product
development opportunities and work to expand the customer support
services that HYCOR customers value most,” said Dr. Neath.
About HYCOR Biomedical, Inc.
Founded in 1981, HYCOR is a global manufacturer and marketer of
in vitro diagnostics products. Since its founding, HYCOR has
expanded its presence into urinalysis, allergy and autoimmune
products used in clinical laboratories, hospitals and doctors’
offices worldwide. Among its products, HYCOR markets t
‘/>”/>
